Germany – Pharmaceutical products – GWQ-Generika-Ausschreibung Rivaroxaban 2,5 mg FTA Auftragsvergabe
GWQ ServicePlus AG awarded a contract of undisclosed value to TAD Pharma GmbH for Healthcare & Medical in September 2024 — one of 207 awards this buyer has made.
Buying agency
GWQ ServicePlus AGWinning supplier
TAD Pharma GmbHContract description
Germany – Pharmaceutical products – GWQ-Generika-Ausschreibung Rivaroxaban 2,5 mg FTA Auftragsvergabe
Related awards · GWQ ServicePlus AG
207 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-131795-2026Novartis Pharma GmbH€125 Feb 2026 Healthcare
- ocds-ted-131852-2026neuraxpharm Arzneimittel GmbH€125 Feb 2026 Healthcare
- ocds-ted-133782-2026AstraZeneca GmbH€125 Feb 2026 Healthcare
Other wins · TAD Pharma GmbH
6 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-283459-2026-1DAK-GesundheitNot disclosed24 Apr 2026 Healthcare
- ocds-ted-317127-2026-2DAK-GesundheitNot disclosed08 May 2026 Healthcare
- ocds-ted-356243-2026-7AOK Baden-Württemberg HauptverwaltungNot disclosed26 May 2026 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for GWQ ServicePlus AG and TAD Pharma GmbH — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back